Delivery Order SPE2DB24D2011-SPE2DB25FBRRQ
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $6,297.80 firm fixed price delivery order for Rabavert rabies vaccine with diluents, effective August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $5,239.50 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a completion date of July 28, 2025. This competitive, firm fixed-price contract was awarded on July 25, 2025, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $40,441.62 for Rabavert rabies vaccine with diluents under a firm fixed-price contract. This non-set-aside award, issued on July 29, 2025, represents a child order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The vaccine will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order valued at $4,900.43 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This competitively awarded, firm fixed-price contract was executed on August 12, 2025, with an ultimate completion date of August 13, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a child delivery order, this award falls under the company's existing...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $2,095.80 by the Defense Logistics Agency for the supply of Rabavert rabies vaccine with diluents. This contract, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed-price transaction with no set-aside designation. The award was competitively procured and reflects AmerisourceBergen's ongoing...
- The Defense Logistics Agency awarded a $2,095.80 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The vaccine will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,310.41 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $1,226.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a completion date of August 12, 2025. The award was made on August 11, 2025, with no set-aside designation, and performance will take place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,931.26 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and specifies performance in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order operates as a child contract under AmerisourceBergen Drug Corp's broader...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, a $13,241.60 firm-fixed-price delivery order contract for RABAVERT rabies vaccine with diluents. This contract has a period of performance through July 25, 2024 and is not set aside for any specific business type. Amerisourcebergen, through its Corporate Office division, is a significant supplier of pharmaceutical products and medical supplies to various federal agencies and...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRRQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,938.28 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of August 28, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, with an extensive portfolio of delivery orders through the DLA Medical Supply Chain covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's federal contracts demonstrate its capability to serve multiple therapeutic domains and government healthcare systems, including the Defense Health Agency and U.S. Coast Guard. This rabies vaccine order fulfills routine immunization supply needs for military and defense personnel, consistent with the company's established role as a primary pharmaceutical supplier to federal defense health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 8/27/25 |